Showing results (121-130 of 2,019) with videos related to

Sort By:
Pageof 202
Antimicrobial Agents and Chemotherapy|October 8, 2014
In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniaeStephan A Kohlhoff, Michael D Huband, Margaret R Hammerschlag
Journal of Clinical Microbiology|May 1, 1994
Performance of three commercially available monoclonal reagents for confirmation of Chlamydia pneumoniae in cell cultureG S Montalban, P M Roblin, M R Hammerschlag
The Journal of Antimicrobial Chemotherapy|September 22, 2001
Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogensM R Hammerschlag, P M Roblin, C M Bébéar
Antimicrobial Agents and Chemotherapy|July 1, 1992
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniaeM R Hammerschlag, K K Qumei, P M Roblin
Expert Review of Anti-Infective Therapy|August 4, 2022
Treatment options for neonatal infections in the post-cefotaxime eraSusannah Franco, Daniel Rampersad, Daniel Mesa, et al.
Best Practice & Research. Clinical Rheumatology|December 5, 2018
The role of HLA-B*27 in spondyloarthritisRobert A Colbert, Fatemeh Navid, Tejpal Gill
Seminars in Immunopathology|January 22, 2021
The enigmatic role of HLA-B*27 in spondyloarthritis pathogenesisFatemeh Navid, Vance Holt, Robert A Colbert
Journal of National Black Nurses' Association : JNBNA|March 21, 2002
African-American women's perceptions of mammography screeningM L Adams, H Becker, A Colbert
Rheumatic Diseases Clinics of North America|November 5, 2013
Update on juvenile spondyloarthritisAnusha Ramanathan, Hemalatha Srinivasalu, Robert A Colbert
Journal of Clinical Microbiology|July 22, 2011
Recurrent intravascular-catheter-related bacteremia caused by Delftia acidovorans in a hemodialysis patientKobkul Chotikanatis, Martin Bäcker, Gabriela Rosas-Garcia, et al.
Pageof 202